Search results for "obesity treatment"

JW Pharmaceutical Files for Phase 3 Trial of Biweekly Obesity Drug Bofanglutide

JW Pharmaceutical Files for Phase 3 Trial of Biweekly Obesity Drug Bofanglutide

JW Pharmaceutical announced on Aug. 18 that it has submitted an Investigational New Drug application to South Korea’s Ministry of Food and Drug...
Forget Wegovy and Mounjaro: How Hanmi’s 'EPPE' Is Redefining Obesity Care

Forget Wegovy and Mounjaro: How Hanmi’s 'EPPE' Is Redefining Obesity Care

Hanmi Pharmaceutical has officially named its in-development obesity treatment "EPPE." Derived from the opening of its international nonproprietary...
Olix Obesity Candidate Reduces Monkeys’ Visceral Fat by 29.2%, Outperforming Global Rival

Olix Obesity Candidate Reduces Monkeys’ Visceral Fat by 29.2%, Outperforming Global Rival

Olix announced on July 30 that its obesity drug candidate, "OLX501A," significantly outperformed a global rival...
Samsung Biologics Bets 2.7 Trillion Won on Peptides in South Korea’s Largest Biotech M&A Deal

Samsung Biologics Bets 2.7 Trillion Won on Peptides in South Korea’s Largest Biotech M&A Deal

Samsung Biologics is making a major push into peptide-based medicines—widely used in weight-loss and diabetes...
Sam Chun Dang Pharm Secures Exclusive U.S. Licensing Deal for Oral Obesity and Diabetes Treatment

Sam Chun Dang Pharm Secures Exclusive U.S. Licensing Deal for Oral Obesity and Diabetes Treatment

Sam Chun Dang Pharm has entered into a significant license-out agreement with an undisclosed U. S.

"It Wasn't Just Weight Loss That Improved My Knees"...Ozempic Study Confirms Cartilage 'Metabolic Changes'

"Please lose some weight. " This is a common phrase heard when visiting a hospital for knee pain.
The Surgeon Who Shed 36kg: Why Willpower Alone Fails Against Severe Obesity

The Surgeon Who Shed 36kg: Why Willpower Alone Fails Against Severe Obesity

It is hard to believe that a cardiothoracic surgeon who repairs hearts was once a patient with "super obesity.
Does Mounjaro Harm Eye Health? Long-Term Study Shows Diabetic Retinopathy Risk Actually Drops

Does Mounjaro Harm Eye Health? Long-Term Study Shows Diabetic Retinopathy Risk Actually Drops

Concerns that Eli Lilly’s popular weight-loss and diabetes treatment, Mounjaro, might exacerbate eye complications in...
High Efficacy and Increased Convenience: The Three Obesity Drugs Awaiting FDA Approval

High Efficacy and Increased Convenience: The Three Obesity Drugs Awaiting FDA Approval

Since the World Health Organization recommended the use of obesity medications for adults last December, the market is...
The Surprising Life-Saving Potential of Weight Loss Meds in Diabetic Foot Care

The Surprising Life-Saving Potential of Weight Loss Meds in Diabetic Foot Care

GLP-1 receptor agonists (such as Wegovy and Ozempic), currently dominating the headlines as weight loss medications,...